HCA Holdings, Inc.
 (HCA)

- NYSE
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Yesterday, 6:12 PM
    • Sabra Health Care REIT (SBRA +2.3%) has a deal to sell its Forest Park Medical Center Frisco Hospital to a unit of HCA, closing a chapter on a bankruptcy filing.
    • The deal is for $96.25M in cash, less assumption of capital lease obligations of about $7.3M. Columbia Medical Center of Plano, a subsidiary of HCA Holdings (HCA +1.2%), is taking on the Frisco Hospital pending a bankruptcy court hearing Feb. 18 to approve the sale.
    • Sabra's expecting to see net proceeds of $89.1M-$94.1M, and thus take a loss in Q1 of $30M-$35M on its intersts in Frisco Hospital and a debtor-in-possession loan issued to the Frisco operators.
    • HCA is up 1.6% after hours.
    | Yesterday, 6:12 PM | 2 Comments
  • Thu, Jan. 28, 10:39 AM
    • HCA Holdings (HCA +1.8%) Q4 results: Revenues: $10,249M (+6.4%); Salaries and Benefits: $4,606M (+7.6%); Supplies: $1,686M (+1.6%); Other Operating Expense: $1,835M (+3.2%); Net Income: $582M (+10.4%); EPS: $1.40 (+17.6%); Non-GAAP EPS: $1.69 (+27.1%).
    • Q4 Operating Statistics: Reported Admissions: 467,300 (+2.0%); Equivalent Admissions: 787,800 (+3.6%); Equivalent Patient Days: 3,850,500 (+4.7%); Inpatient Surgery Cases: 134,000 (+1.1%); Outpatient Surgery Cases: 240,200 (+2.9%); Emergency Room Visits: 2,037,700 (+4.5%).
    • FY2015 results: Revenues: $39,678M (+7.5%); Salaries and Benefits: $18,115M (+8.9%); Supplies: $6,638M (+6.0%); Other Operating Expense: $7,103M (+5.2%); Net Income: $2,129M (+13.5%); EPS: $4.99 (+20.0%); Non-GAAP EPS: $5.56 (+18.3%); Quick Assets: $741M (+30.9%).
    • FY2015 Operating Statistics: Reported Admissions: 1,868,800 (+4.1%); Equivalent Admissions: 3,122,700 (+5.5%); Equivalent Patient Days: 15,299,100 (+6.7%); Inpatient Surgery Cases: 529,900 (+2.1%); Outpatient Surgery Cases: 909,400 (+2.0%); Emergency Room Visits: 8,050,200 (+8.0%).
    • 2016 Guidance: Revenues: $41.5B - 42.5B; Adjusted EBITDA: $8.15B - 8.45B; Adjusted EPS: $6.00 - 6.45; CAPEX: ~$2.7B.
    | Thu, Jan. 28, 10:39 AM
  • Thu, Jan. 28, 9:23 AM
    | Thu, Jan. 28, 9:23 AM | 16 Comments
  • Thu, Jan. 28, 8:41 AM
    • HCA Holdings (NYSE:HCA): Q4 EPS of $1.69 beats by $0.30.
    • Revenue of $10.25B (+6.3% Y/Y) beats by $90M.
    • Press Release
    | Thu, Jan. 28, 8:41 AM | 1 Comment
  • Wed, Jan. 27, 5:30 PM
    | Wed, Jan. 27, 5:30 PM | 18 Comments
  • Mon, Jan. 11, 9:15 AM
    | Mon, Jan. 11, 9:15 AM | 2 Comments
  • Fri, Jan. 8, 5:01 PM
    • On a preliminary basis, HCA Holdings (NYSE:HCA) expects its 2015 non-GAAP EBITDA to be $7.9B, slightly higher than its guidance of $7.8B.
    • Same facility admissions, same facility equivalent admissions and same facility emergency room admissions are expected to increase 1.6%, 2.9% and 3.6%, respectively, yoy.
    • Final results will be released in the next three to four weeks.
    | Fri, Jan. 8, 5:01 PM
  • Dec. 18, 2015, 12:18 PM
    • Biogen (BIIB +0.2%) initiated with Overweight rating and $344 (16% upside) price target by Atlantic Equities.
    • CVS Health (CVS -0.1%) initiated with Overweight rating and $110 (16% upside) price target by Barclays.
    • Clovis Oncology (CLVS +0.9%) initiated with Buy rating and $50 (48% upside) price target by Janney.
    • Relypsa (RLYP +2.6%) initiated with Buy rating and $63 (123% upside) price target by H.C. Wainwright.
    • HCA Holdings (HCA -0.2%) initiated with Outperform rating and $75 (16% upside) price target; LifePoint Health (LPNT +0.4%) with an Outperform rating and $79 (13% upside) price target; Tenet Healthcare (THC +1.2%) with a Neutral rating and $33 (18% upside) price target and Universal Health Services (UHS +0.4%) with a Neutral rating and $129 (11% upside) price target by Credit Suisse.
    • Amgen (AMGN -0.1%) upgraded to Overweight from Equal Weight by Morgan Stanley. Price target raised to $193 (20% upside) from $160.
    • Valeant Pharmaceuticals (VRX -1.8%) downgraded to Neutral from Buy by Mizuho Securities. Price target raised to $130 (19% upside) from $111.
    | Dec. 18, 2015, 12:18 PM
  • Dec. 3, 2015, 9:38 AM
    • HCA Holdings (HCA +0.6%) commences a public offering of $500M aggregate principal amount of 5.875% senior notes due 2026. The notes will trade interchangeably with the $1.0B aggregate principal amount of 5.875% senior notes due 2026 issued by the company on November 13.
    • Net proceeds will be used for general corporate purposes.
    | Dec. 3, 2015, 9:38 AM
  • Nov. 23, 2015, 2:47 PM
    • Goldman Sachs' Hedge Fund VIP list of the 50 most-heavily-owned stocks have trailed the S&P 500 by about 500 basis points (down 2% vs. the S&P's 3% gain) year-to-date, including 720 basis points of underperformance since the start of October (down about 8% vs. down about 1%).
    • Call it the Valeant effect: Health-care stocks have accounted for about 70% of the year-to-date 2% decline.
    • Based on the most recent filing, hedge funds are bailing on some of their poorer performers, including Valeant (NYSE:VRX), HCA Holdings (NYSE:HCA), Endo (NASDAQ:ENDP), Ally Financial (NYSE:ALLY), and NorthStar Realty (NYSE:NRF), and have instead placed bets on Baidu (NASDAQ:BIDU), Mylan (NASDAQ:MYL), MGM Resorts (NYSE:MGM), and GE.
    • After the shakeup, the top five hedge fund hotels: Allergan (NYSE:AGN), Facebook (NASDAQ:FB), Alphabet (GOOG, GOOGL), Time Warner Cable (NYSE:TWC), and Amazon (NASDAQ:AMZN).
    | Nov. 23, 2015, 2:47 PM | 13 Comments
  • Oct. 27, 2015, 10:29 AM
    • HCA Holdings (HCA +1.1%) Q3 results: Revenues: $9,856M (+6.9%); Salaries and Benefits: $4,619M (+9.7%); Supplies: $1,644M (+6.8%); Other Operating Expenes: $1,796M (+6.4); Adjusted EBITDA: $1,815M (-0.7%); Net Income: $449M (-13.3%); EPS: $1.05 (-9.5%); Quick Assets: $588M (+3.9%).
    • Reported Admissions: 466,400 (+3.8%); Equivalent Admissions: 787,300 (+4.8%); Revenue per Equivalent Admission: 12,517 (+2.0%); Inpatient Surgery Cases: 134,000 (+2.1%); Outpatient Surgery Cases: 226,400 (+1.7%); ER Visits: 2,023,100 (+7.2%).
    • 2015 Guidance: Non-GAAP EBITDA: ~ $7.8B; Non-GAAP EPS: $5.20 - 5.25.
    | Oct. 27, 2015, 10:29 AM
  • Oct. 27, 2015, 8:32 AM
    • HCA Holdings (NYSE:HCA): Q3 EPS of $1.17 misses by $0.03.
    • Revenue of $9.9B (+7.4% Y/Y) in-line.
    | Oct. 27, 2015, 8:32 AM
  • Oct. 26, 2015, 5:30 PM
    | Oct. 26, 2015, 5:30 PM | 33 Comments
  • Oct. 22, 2015, 9:26 AM
    | Oct. 22, 2015, 9:26 AM
  • Oct. 22, 2015, 9:14 AM
    | Oct. 22, 2015, 9:14 AM
  • Oct. 15, 2015, 9:13 AM
    | Oct. 15, 2015, 9:13 AM
Company Description
HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.
Sector: Healthcare
Industry: Hospitals
Country: United States